Skip to content

Insider · CIK 0001669207

Timothy L. Moore

officerdirector

Files at BLFS (BIOLIFE SOLUTIONS INC), CERS (CERUS CORP), ALLO (Allogene Therapeutics, Inc.). First filing Feb 5, 2025, latest Feb 5, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $25k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ALLO: Allogene Therapeutics, Inc.

ALLOOct 9, 2026 · close 1.46

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
35Weak
ALLOsell 5
Allogene Therapeutics, Inc.
$25k
14,746 shares
-6%0% from low-48% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 6, 2026BLFS
BIOLIFE SOLUTIONS INC
DDisposition to issuer
Common Stock
-44,943--04 d ago
Jun 3, 2025CERS
CERUS CORP
AGrant or award
Common Stock
+60,000$0.00$0205,073Jun 4, 2025
Mar 18, 2025BLFS
BIOLIFE SOLUTIONS INC
AGrant or award
Common Stock
+6,876--36,773Mar 20, 2025
Feb 3, 2025ALLO
Allogene Therapeutics, Inc.
SOpen-market sale
Common Stock
-14,746$1.71$25k250,713Feb 5, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Timothy L. Moore: insider trades and track record | InsiderTell